Unsubstantiated concerns over the safety of use of sulphonylureas and insulin for increased risk of diabetes complications

J Diabetes. 2014 Jan;6(1):30-2. doi: 10.1111/1753-0407.12082. Epub 2013 Sep 18.

Authors

Jianping Weng¹, Xilin Yang

Affiliation

¹ Department of Endocrinology, The Third Affiliated Hospital, Sun Yat-Sen University, Guanzhou. [email protected].

PMID: 23944992
DOI: 10.1111/1753-0407.12082

No abstract available

Publication types

Comment

MeSH terms

Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / mortality*
Female
Humans
Hypoglycemic Agents / therapeutic use*
Insulin / therapeutic use*
Male
Metformin / therapeutic use*
Sulfonylurea Compounds / therapeutic use*

Substances

Hypoglycemic Agents
Insulin
Sulfonylurea Compounds
Metformin